Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Nature Biotechnology
|
August 12, 2025
Jefferson et al. reply
Osmat Jefferson, W Nicholson Price, S Sean Tu, et al.
Nature Biotechnology
|
March 18, 2026
Innovation and policy challenges of AI-drug hybrids
Andreas Panagopoulos, Katerina Sideri, I Glenn Cohen, et al.
Nature Biotechnology
|
March 18, 2025
The puzzle of biologics manufacturing platform patents
Osmat Azzam Jefferson, W Nicholson Price, S Sean Tu, et al.
JAMA Network Open
|
March 5, 2026
Factors for Patient Trust and Acceptance of Medical Artificial Intelligence
Ana Bracic, Kayte Spector-Bagdady, Sophie Towle, et al.
The Hastings Center Report
|
January 21, 2015
The authors reply
Paul S Appelbaum, Wendy Chung, Abby J Fyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 26, 2013
Informed consent for return of incidental findings in genomic research
Paul S Appelbaum, Cameron R Waldman, Abby Fyer, et al.
The Hastings Center Report
|
June 13, 2014
Models of consent to return of incidental findings in genomic research
Paul S Appelbaum, Erik Parens, Cameron R Waldman, et al.
Health Affairs (Project Hope)
|
December 6, 2021
Respecting Autonomy And Enabling Diversity: The Effect Of Eligibility And Enrollment On Research Data Demographics
Kayte Spector-Bagdady, Shengpu Tang, Sarah Jabbour, et al.
The Hastings Center Report
|
November 2, 2024
Synthetic Health Data: Real Ethical Promise and Peril
Daniel Susser, Daniel S Schiff, Sara Gerke, et al.
Health Affairs (Project Hope)
|
January 22, 2025
Artificial Intelligence In Health And Health Care: Priorities For Action
Michael E Matheny, Jennifer C Goldsack, Suchi Saria, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Nature Biotechnology
|
August 12, 2025
Jefferson et al. reply
Osmat Jefferson, W Nicholson Price, S Sean Tu, et al.
Nature Biotechnology
|
March 18, 2026
Innovation and policy challenges of AI-drug hybrids
Andreas Panagopoulos, Katerina Sideri, I Glenn Cohen, et al.
Nature Biotechnology
|
March 18, 2025
The puzzle of biologics manufacturing platform patents
Osmat Azzam Jefferson, W Nicholson Price, S Sean Tu, et al.
JAMA Network Open
|
March 5, 2026
Factors for Patient Trust and Acceptance of Medical Artificial Intelligence
Ana Bracic, Kayte Spector-Bagdady, Sophie Towle, et al.
The Hastings Center Report
|
January 21, 2015
The authors reply
Paul S Appelbaum, Wendy Chung, Abby J Fyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 26, 2013
Informed consent for return of incidental findings in genomic research
Paul S Appelbaum, Cameron R Waldman, Abby Fyer, et al.
The Hastings Center Report
|
June 13, 2014
Models of consent to return of incidental findings in genomic research
Paul S Appelbaum, Erik Parens, Cameron R Waldman, et al.
Health Affairs (Project Hope)
|
December 6, 2021
Respecting Autonomy And Enabling Diversity: The Effect Of Eligibility And Enrollment On Research Data Demographics
Kayte Spector-Bagdady, Shengpu Tang, Sarah Jabbour, et al.
The Hastings Center Report
|
November 2, 2024
Synthetic Health Data: Real Ethical Promise and Peril
Daniel Susser, Daniel S Schiff, Sara Gerke, et al.
Health Affairs (Project Hope)
|
January 22, 2025
Artificial Intelligence In Health And Health Care: Priorities For Action
Michael E Matheny, Jennifer C Goldsack, Suchi Saria, et al.
Page
of 5